Brussonol and komaroviquinone as inhibitors of the SARS-CoV-2 Omicron BA.2 variant spike protein: A molecular docking, molecular dynamics, and quantum biochemistry approach

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 8fc53c8a8cb71758-LAX IP: 101.37.83.79 UTC time: 2025-01-03T19:01:16+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4